Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
UK Research and Innovation
Polaris House, North Star Avenue
SWINDON
SN21UH
UK
Contact person: Goods and Self Service
E-mail: coreservices@uksbs.co.uk
NUTS: UK
Internet address(es)
Main address: www.uksbs.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
Additional information can be obtained from the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Other: Research
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework
Reference number: GSS23743
II.1.2) Main CPV code
73111000
II.1.3) Type of contract
Services
II.1.4) Short description
***For the avoidance of doubt, this is not a call for competition. This notice is to inform the market of a Future Opportunity***
UK Research and Innovation (UKRI) brings together the seven Research Councils (AHRC, BBSRC, EPSRC, ESRC, MRC, NERC, STFC) plus Innovate UK and a new organisation, Research England.
UKRI wishes to establish a Framework for the provision of Antibodies.
It is intended that the Framework will be based upon four LOTS:
LOT 1 - Primary Unconjugated
LOT 2 - Primary Conjugated
LOT 3 - Secondary Unconjugated
LOT 4 - Secondary Conjugated
The objective of this procurement will be to:
a) Produce a Framework Agreement that UKRI can easily use and provide a compliant route to market.
b) Capture a large percentage of the Antibodies requirements from large value items to low value, high volume items.
c) Develop strong relationships with UKRI and Suppliers to ensure that the requirements are captured and value for money is achieved.
d) To capture quality management information that will support informed decision making in future procurements.
e) To ensure sustainability aspects are considered and integrated into the Framework Agreement.
f) To continuously improve and apply best practice procurement that meets the end users' requirements.
****There is no commitment at this stage that the above mentioned opportunity will proceed in its current format****
***GSS23743 Supplier Day***
In order for Suppliers to obtain an overview of the requirement, UK SBS on behalf of UKRI will be holding a Supplier day on Tuesday 10th October 2023 at 15:00hrs GMT, and Wednesday 11th October 2023 at 14:00hrs GMT. The duration of the Supplier day will be approximately 1 hour and will be held online.
If you wish to attend, please complete the attached form: https://forms.office.com/e/xvtvVt4wce confirming your attendance and select your preferred date no later than Friday 6th October 2023 at 14:00hrs GMT.
Please note that a maximum of two representatives per organisation is permitted.
Following confirmation of attendance, a link to the supplier day will be shared with confirmed attendees.
Any information supplied shall not place any supplier at an advantage in a potential procurement process.
II.1.5) Estimated total value
Value excluding VAT:
9 600 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.2) Description
Lot No: 1
II.2.1) Title
LOT 1 - Primary Unconjugated
II.2.2) Additional CPV code(s)
24000000
33140000
71900000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
UKRI wish to put in place a Framework for the provision of Primary Unconjugated Antibodies
Lot No: 2
II.2.1) Title
LOT 2 - Primary Conjugated
II.2.2) Additional CPV code(s)
24000000
33140000
71900000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
UKRI wish to put a Framework in place for the provision of Primary Conjugated Antibodies
Lot No: 3
II.2.1) Title
LOT 3 - Secondary Unconjugated
II.2.2) Additional CPV code(s)
24000000
33140000
71900000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
UKRI wish to put in place a Framework for the provision of Secondary Unconjugated Antibodies
Lot No: 4
II.2.1) Title
LOT 4 - Secondary Conjugated
II.2.2) Additional CPV code(s)
24000000
33140000
71900000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
UKRI wish to put in place a Framework for the provision of Secondary Conjugated Antibodies
II.3) Estimated date of publication of contract notice:
06/12/2023
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section VI: Complementary information
VI.3) Additional information
The Terms and Conditions for this requirement are available to view on Contracts Finder www.contractsfinder.service.gov.uk
it is to be noted that there is no commitment at this stage that the above mentioned opportunity will proceed in its current format.
VI.5) Date of dispatch of this notice
26/09/2023